Results for procjenjivala translation from Croatian to English

apsolutna bioraspoloživost supkutano primjenjenog kanakinumaba procjenjivala se na 66%.
the absolute bioavailability of subcutaneously administered canakinumab was estimated to be 66%.

kao mjera ishoda za sigurnost primjene procjenjivala se incidencija prijeloma.
fracture incidence was evaluated as a safety endpoint.

klinička studija provedena u latinskoj americi procjenjivala je rotarix u više od 20 000 osoba.
a clinical study performed in latin america evaluated rotarix in more than 20000 subjects.

sva tri ispitivanja faze 3 procjenjivala su djelotvornost ledipasvira/sofosbuvira s ribavirinom ili bez njega.
all three phase 3 studies evaluated the efficacy of ledipasvir/sofosbuvir with or without ribavirin.

farmakokinetika liraglutida procjenjivala se u bolesnika s različitim stupnjevima oštećenja jetre u ispitivanju s jednom dozom lijeka.
the pharmacokinetics of liraglutide was evaluated in patients with varying degree of hepatic impairment in a single­dose trial.

u bolesnika liječenih infliksimabom bilo je vidljivo značajno poboljšanje u funkcionalnoj sposobnosti koja se procjenjivala haq-om.
infliximab-treated patients demonstrated significant improvement in physical function as assessed by haq.

u nekliničkom ispitivanju procjenjivala se sposobnost induciranja zaštite protiv homolognih i heterolognih sojeva u cjepivu pomoću modela primjene na tvorovima.
the ability to induce protection against homologous and heterologous vaccine strains was assessed non-clinically using ferret challenge models.

ipilimumab se primjenjivao u približno 10 000 bolesnika u kliničkom programu kojim se procjenjivala njegova primjena u različitim veličinama doza i vrstama tumora.
ipilimumab has been administered to approximately 10,000 patients in a clinical program evaluating its use with various doses and tumour types.

djelotvornost i sigurnost primjene kaspofungina procjenjivala se u pedijatrijskih bolesnika u dobi od 3 mjeseca do 17 godina u dva prospektivna, multicentrična klinička ispitivanja.
the safety and efficacy of caspofungin was evaluated in paediatric patients 3 months to 17 years of age in two prospective, multicenter clinical trials.

trombolitici: sigurnost istodobne primjene klopidogrela, fibrinskih ili afibrinskih specifičnih trombolitika i heparina procjenjivala se u bolesnika s akutnim infarktom miokarda.
thrombolytics: the safety of the concomitant administration of clopidogrel, fibrin or non-fibrin specific thrombolytic agents and heparins was assessed in patients with acute myocardial infarction.

distribucija rilpivirina u druge odjeljke osim plazme (npr. cerebrospinalni likvor, sekrete genitalnog trakta) nije se procjenjivala u ljudi.
the distribution of rilpivirine into compartments other than plasma (e.g., cerebrospinal fluid, genital tract secretions) has not been evaluated in humans.

farmakokinetička svojstva amprenavira nakon istodobne primjene lijeka telzir s ritonavirom procjenjivala su se na zdravim odraslim ispitanicima i bolesnicima inficiranim hiv-om te nije primijećena značajna razlika između te dvije skupine.
the pharmacokinetic properties of amprenavir following co-administration of telzir with ritonavir have been evaluated in healthy adult subjects and hiv-infected patients and no substantial differences were observed between these two groups.

u multicentričnom prospektivnom ispitivanju faze ii u kojemu se procjenjivala sigurnost i djelotvornost peroralno primijenjenog tmz-a u liječenju bolesnika s prvim relapsom anaplastičnog astrocitoma, šestomjesečni pfs iznosio je 46 %.
in a multicentre, prospective phase ii trial evaluating the safety and efficacy of oral tmz in the treatment of patients with anaplastic astrocytoma at first relapse, the 6 month pfs was 46 %.

dok su ranija izviješća procjenjivala kako se broj žrtava trgovine ljudima u cijelom svijetu godišnje kreće između 700.000 i 4 milijuna, izviješće za 2003. godinu taj broj reducira na procijenjenih 800.000 do 900.000 ljudi.
while earlier reports placed the estimated number of human trafficking victims around the world at between 700,000 and 4 million annually, the 2003 tip report scales back that number to an estimated 800,000 to 900,000 people.

cp-ai-006 je bilo otvoreno ispitivanje nastavka liječenja nakon ispitivanja cp-ai-005 i cp-ai-007 kojim se procjenjivala sigurnost ponavljane izloženosti aztreonamu i učinak na ishode povezane s bolešću tijekom više 28-dnevnih kura.
cp-ai-006 was an open-label follow-on study to cp-ai-005 and cp-ai-007 evaluating the safety of repeated exposure to aztreonamand the effect on disease-related endpoints over multiple 28-day courses.